Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14695199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil

  2003cited by this paper
• Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast

  2003cited by this paper
• Fibronectin in malignancy.

  2002cited by this paper
• Melanoma development and progression: a conspiracy between tumor and host.

  2002cited by this paper
• Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.

  2002cited by this paper
• Domain structure and organisation in extracellular matrix proteins.

  2002cited by this paper
• Role of stroma in carcinogenesis of the prostate.

  2002cited by this paper
• Tumour-stroma interactions: Phenotypic and genetic alterations in mammary stroma: implications for tumour progression

  2001cited by this paper
• Identification and characterization of a novel fibronectin in zebrafish.

  2001cited by this paper
• Stromal cells can contribute oncogenic signals.

  2001cited by this paper
• Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.

  2001cited by this paper
• Reactive stroma in prostate cancer progression.

  2001cited by this paper
• ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins

  2001cited by this paper
• Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.

  2000cited by this paper
• The influence of the microenvironment on the malignant phenotype.

  2000cited by this paper
• Expression and Functional Characteristics of Calpain 3 Isoforms Generated through Tissue-Specific Transcriptional and Posttranscriptional Events

  1999cited by this paper
• Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

  1999cited by this paper
• Control of mRNA decay by heat shock-ubiquitin-proteasome pathway.

  1999cited by this paper
• Motogenic activity of IGD-containing synthetic peptides.

  1999cited by this paper
• Genetic pathways in colorectal and other cancers.

  1999cited by this paper
• Assessment of Vascularity in Histological Sections: Effects of Methodology and Value as an Index of Angiogenesis in Breast Tumours

  1998cited by this paper
• The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading.

  1997cited by this paper
• Novel Exonic Elements That Modulate Splicing of the Human Fibronectin EDA Exon*

  1997cited by this paper
• The fibronectin gene as a model for splicing and transcription studies

  1996cited by this paper
• Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin.

  1996influential reference
• Molecular defects in TCRBV genes preclude thymic selection and limit the expressed TCR repertoire.

  1996cited by this paper
• Alternative splicing of fibronectin--many different proteins but few different functions.

  1995cited by this paper
• Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases.

  1995cited by this paper
• The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis

  1994cited by this paper
• Cytokine control of cell motility: modulation and mediation by the extracellular matrix.

  1994cited by this paper
• Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues

  1994cited by this paper
• Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function

  1994cited by this paper
• Alternative pre-mRNA splicing: factors involved in splice site selection.

  1994cited by this paper
• Superfibronectin is a functionally distinct form of fibronectin

  1994cited by this paper
• Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma

  1994cited by this paper
• An amino-terminal fibronectin fragment stimulates the differentiation of ST-13 preadipocytes.

  1993cited by this paper
• RNA-RNA in situ hybridization using digoxigenin-labeled probes: the use of high-molecular-weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction.

  1993cited by this paper
• Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.

  1993cited by this paper
• Elements regulating an alternatively spliced exon of the rat fibronectin gene

  1993cited by this paper
• Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation

  1992cited by this paper
• Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.

  1992cited by this paper
• Biochemical mechanisms of constitutive and regulated pre-mRNA splicing.

  1991cited by this paper
• Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells.

  1991cited by this paper
• Migration stimulating activity in serum of breast cancer patients.

  1991cited by this paper
• Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: Effect on hyaluronic acid synthesis

  1989cited by this paper
• Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.

  1989cited by this paper
• The Interaction of Fibronectin (fn) with Native, Polymeric Collagen (Collagen Fibres): Comparison with von Willebrand Factor (vWf)-Binding by Collagen

  1989cited by this paper
• Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression

  1989cited by this paper
• Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.

  1988cited by this paper
• Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment.

  1988cited by this paper
• Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells.

  1988cited by this paper
• Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites.

  1987cited by this paper
• Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial‐mesenchymal interactions

  1987cited by this paper
• Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro.

  1987cited by this paper
• Cloning and analysis of the promotor region of the human fibronectin gene.

  1987cited by this paper
• Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease.

  1987cited by this paper
• Occurrence of a fetal fibroblast phenotype in familial breast cancer

  1986cited by this paper
• Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during foetal development.

  1985cited by this paper
• Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels.

  1985cited by this paper
• Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro.

  1984cited by this paper
• Cell proliferation and migration on collagen substrata in vitro.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Oncofetal Reprogramming: A New Frontier in Cancer Therapy Resistance

  2026cites this paper
• The In Vitro Effects of Romina Strawberry Extract on 3D Uterine Leiomyosarcoma Cells

  2023cites this paper
• High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.

  2023cites this paper
• Oncofetal reprogramming in tumour development and progression

  2022cites this paper
• Identification and functional characterization of imbalanced osteoarthritis-associated fibronectin splice variants

  2022cites this paper
• Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages

  2022cites this paper
• Proteomic Signature of Extracellular Vesicles for Lung Cancer Recognition

  2021cites this paper
• Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.

  2021cites this paper
• Characterisation of Collagen Re-Modelling in Localised Prostate Cancer Using Second-Generation Harmonic Imaging and Transrectal Ultrasound Shear Wave Elastography

  2021cites this paper
• Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts

  2020cites this paper
• FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer

  2020cites this paper
• Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends

  2019cites this paper
• Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth

  2018cites this paper
• Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells

  2018cites this paper
• Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.

  2018cites this paper
• 2 Functions of Diverse Myeloid Cells in the Tumor MicroEnvironment

  2017cites this paper
• Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin

  2017cites this paper
• Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin

  2017cites this paper
• Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin

  2017cites this paper
• Plasma fibronectin stabilizes Borrelia burgdorferi–endothelial interactions under vascular shear stress by a catch-bond mechanism

  2017cites this paper
• FN1–EGF gene fusions are recurrent in calcifying aponeurotic fibroma

  2016cites this paper
• Unleashing Cancer Cells on Surfaces Exposing Motogenic IGDQ Peptides.

  2016cites this paper
• Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma

  2016cites this paper
• Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer

  2016cites this paper
• The Role of Stroma in Tumor Development.

  2015cites this paper
• The mechanical microenvironment in cancer: How physics affects tumours.

  2015cites this paper
• Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents.

  2015cites this paper
• in Development.

  2015cites this paper
• InsidiousChanges inStromalMatrix FuelCancerProgression

  2015cites this paper
• Migration Stimulating Factor : new marker for tumour progression?

  2015cites this paper
• Distinct phenotype and therapeutic potential of gingival fibroblasts.

  2014cites this paper
• Insidious Changes in Stromal Matrix Fuel Cancer Progression

  2014cites this paper
• A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value

  2014cites this paper
• The evolution of the cancer niche during multistage carcinogenesis

  2013cites this paper
• Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.

  2013cites this paper
• Migration Stimulating Factor : the search for inhibitors

  2013cites this paper
• Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.

  2013cites this paper
• The expression and role of Migration Stimulating Factor (MSF) in oral tumours

  2012influential citation
• Functions of Diverse Myeloid Cells in the Tumor Micro-Environment

  2012cites this paper
• Complex Regulation of the Pericellular Proteolytic Microenvironment during Tumor Progression and Wound Repair: Functional Interactions between the Serine Protease and Matrix Metalloproteinase Cascades

  2012cites this paper
• IGD Motifs, Which Are Required for Migration Stimulatory Activity of Fibronectin Type I Modules, Do Not Mediate Binding in Matrix Assembly

  2012cites this paper
• Metabolic remodeling of the tumor microenvironment

  2012cites this paper
• Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

  2012cites this paper
• Biomaterials in regenerative medicine: engineering to recapitulate the natural.

  2012cites this paper
• Bistable switch in migration stimulating factor expression: Regulation by the concerted signalling of transforming growth factor‐β1 and the extracellular matrix

  2012cites this paper
• Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

  2011cites this paper
• Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma

  2011cites this paper
• Mechanical forces and tumor cells: Insight into the biophysical aspects of cancer progression

  2011cites this paper
• Migration-stimulating factor as a novel biomarker in salivary gland tumours.

  2011cites this paper
• Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

  2011cites this paper
• Cryptic activities of fibronectin fragments, particularly cryptic proteases.

  2011cites this paper
• Myeloid cell diversification and complexity: an old concept with new turns in oncology

  2011cites this paper
• Alternative splicing: a promising target for pharmaceutical inhibition of pathological angiogenesis?

  2010cites this paper
• Tumor Cell Motility Marker for M 2-Polarization , Influencing Migration-Stimulating Factor : A New Tumor-Conditioned Macrophages Secrete and Paola

  2010cites this paper
• Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility

  2010influential citation
• Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).

  2010cites this paper
• Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT.

  2010cites this paper
• Cooperative Binding and Activation of Fibronectin by a Bacterial Surface Protein*

  2010cites this paper
• Fibronectin structure: a new piece of the puzzle emerges.

  2010cites this paper
• Zinc induces structural reorganization of gelatin binding domain from human fibronectin and affects collagen binding.

  2010cites this paper
• pAI-1: A Multifunctional seRpIn with complex Roles in cell signaling and Migration

  2010cites this paper
• Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion

  2010cites this paper
• Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment.

  2010cites this paper
• Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention

  2010cites this paper
• Epithelial and Mesenchymal Cell Biology Epithelial-Stromal Interaction 1 ( EPSTI 1 ) Substitutes for Peritumoral Fibroblasts in the Tumor Microenvironment

  2010cites this paper
• Tumors as organs: complex tissues that interface with the entire organism.

  2010cites this paper
• Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling

  2009cites this paper
• The myofibroblast, electron microscopy and cancer research

  2009cites this paper
• Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target*S

  2009cites this paper
• Identification of a Novel Family of Laminin N-terminal Alternate Splice Isoforms

  2009cites this paper
• Motogenic Sites in Human Fibronectin Are Masked by Long Range Interactions

  2009cites this paper
• Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin.

  2009cites this paper
• Liberation of an N-terminal proline-rich peptide from the cryptic proteinase of fibronectin by auto-proteolysis.

  2008cites this paper
• Macro-environment of breast carcinoma: frequent genetic alterations in the normal appearing skins of patients with breast cancer

  2008cites this paper
• Influences of tumor stroma on the malignant phenotype.

  2008cites this paper
• Migratory neighbors and distant invaders: tumor-associated niche cells.

  2008cites this paper
• Studies of focal adhesion assembly.

  2008cites this paper
• The myofibroblast and its tumours

  2008cites this paper
• The effect of cell-matrix interactions and aging on the malignant process.

  2007cites this paper
• Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).

  2007cites this paper
• Structural and functional characterisation of the collagen binding domain of fibronectin

  2007cites this paper
• Tumorigenesis and Neoplastic Progression Epigenetic Reversion of Breast Carcinoma Phenotype Is Accompanied by Changes in DNA Sequestration as Measured by Alu I Restriction Enzyme

  2007cites this paper
• Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration

  2007cites this paper
• The Role of the Fibronectin IGD Motif in Stimulating Fibroblast Migration*

  2007cites this paper
• Epigenetic reversion of breast carcinoma phenotype is accompaniedby DNA sequestration

  2006cites this paper
• A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay.

  2006cites this paper
• Neoplastic growth through the developmental stages of the organism.

  2005cites this paper
• Fibronectin fragmentation promotes alpha4beta1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix.

  2005cites this paper
• Keystone symposium: The role of microenvironment in tumor induction and progression, Banff, Canada, 5–10 February 2005

  2005cites this paper
• Synthesis of an IGD peptidomimetic with motogenic activity.

  2005cites this paper
• Identification and characterization of a second fibronectin gene in zebrafish.

  2005cites this paper
• Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts.

  2005cites this paper
• Developmental biology of fibroblasts and neoplastic disease.

  2005cites this paper
• The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.

  2005cites this paper
• Migration‐stimulating factor displays HEXXH‐dependent catalytic activity important for promoting tumor cell migration

  2005influential citation
• Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

  2005cites this paper
• A Visual-Quantitative Analysis of Fibroblastic Stromagenesis in Breast Cancer Progression

  2004cites this paper
• Regulation of matrix biology by matrix metalloproteinases.

  2004cites this paper
• Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes

  year unknowncites this paper